Literature DB >> 25726738

Preventing diverticulitis: mesalamine may still be indicated in the decision.

Martin H Floch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25726738     DOI: 10.1053/j.gastro.2015.02.011

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  1 in total

1.  Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.

Authors:  W Kruis; V Kardalinos; T Eisenbach; M Lukas; T Vich; I Bunganic; J Pokrotnieks; J Derova; J Kondrackiene; R Safadi; D Tuculanu; Z Tulassay; J Banai; A Curtin; A E Dorofeyev; S F Zakko; N Ferreira; S Björck; M M Diez Alonso; J Mäkelä; N J Talley; K Dilger; R Greinwald; R Mohrbacher; R Spiller
Journal:  Aliment Pharmacol Ther       Date:  2017-05-23       Impact factor: 8.171

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.